insights_auto
Why is 3696 down 2.16%?
Dive Deeperchevron_right
3696:HKG
Insilico Medicine Cayman TopCo
HK$47.20
arrow_downward
-2.16%(-1.04) 1D
Oct 9, 9:35:56 AM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3696...
Open
HK$48.50
High
HK$48.60
Low
HK$46.60
Mkt. cap
26.42B
Avg. vol.
14.95M
Volume
3.30M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.20
Shares outstanding
557.42M
No. of employees
333
Open
HK$48.50
High
HK$48.60
Low
HK$46.60
Mkt. cap
26.42B
Avg. vol.
14.95M
Volume
3.30M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.20
Shares outstanding
557.42M
No. of employees
333
News stories
From web sources and news partners
CNBC
·
2 hours ago
Tokenization could unleash tens of billions of dollars in trapped capital, Nasdaq CEO says
Investing.com
·
7 minutes ago
Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Mitrade
·
14 minutes ago
Nasdaq Drops Over 300 Points After OpenAI's Revenue Comes In $20 Billion Short
Investor's Business Daily
·
1 hour ago
Dow Jones Futures: AI Stocks Tumble On OpenAI News; SpaceX Move Slams Verizon, AT&T Late
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees333
Founded2014
Headquarters-
SectorHealth care
Websiteinsilico.com